Ligand-targeted ADCs are a unique subclass of ADCs directed against cell surface-tethered ligands enriched on tumor cells, such as inhibitory Notch ligand delta-like ligand 3 (DLL3) and Siglec-9 ligand galectin 3 binding protein (LGALS3BP) [214,215]. Here, LGALS3BP is linked to neoplasm.